| Name | Title | Contact Details |
|---|
Founded at MIT, the Embr Wave® & Wave 2 are personal cooling bands and heated wearables for fast, natural thermal wellness and thermotherapy.
"Eleven uses its proprietary technology platform to create first-of-a-kind protein therapeutics to address unmet needs for ophthalmic diseases. Proteins are able to modulate inflammatory cytokines, key targets in ocular disease that have been difficult to access with conventional therapeutic approaches. A significant untapped opportunity exists for protein therapeutics to address ophthalmic diseases, and Eleven is applying its advanced protein technology and expertise to develop innovative medicines for patients suffering from ocular diseases. Eleven`s team of industry veterans has deep experience in understanding protein science and biologic drug development, designing and conducting clinical trials and, most importantly, applying specific expertise in ophthalmic disease to create novel ocular therapeutics to treat unmet medical needs. Eleven has developed a proprietary pipeline of ophthalmic drug candidates derived from the company`s innovative AMP-Rx protein engineering technology. The company`s initial product candidates are focused on targeting inflammatory cytokines and key targets of ocular disease by blocking the cytokines and modulating the biological processes that drive ocular disease. Current pipeline opportunities include ocular surface diseases such as dry eye disease (DED) and allergic conjunctivitis (AC), and back of the eye diseases such as diabetic macular edema (DME) and uveitis. In addition, Eleven’s proprietary technology has been utilized to prolong the intravitreal half-life of our pipeline products. Beyond its internal drug development programs, Eleven works with collaborators, such as ThromboGenics, to apply its innovative protein therapeutic design capabilities to engineer and develop biotherapeutic products for additional therapeutic targets. EBI-005, Eleven`s lead product candidate, is a novel interleukin-1 (IL-1) receptor antagonist in Phase 3 clinical development as one of the first topically administered proteins for the treatment of DED and AC, two inflammatory diseases at the surface of the eye."
MedicineNet is a San Clemente, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
The Fertility Institutes is a world leading fertility center that offers a variety of fertility services including gender selection, PGD genetic screening, surrogacy, egg donors, IVF, and egg freezing.
ConsumerMedical is a leading healthcare decision support and concierge company serving approximately 3 million individuals through some of the nation`s largest employers` health plans and private exchanges. As a Medical Ally` ConsumerMedical guides participants throughout their healthcare journey with compassionate` high-touch support and deep clinical expertise. ConsumerMedical offers a fully integrated suite of solutions including Medical Decision Support` Expert Medical Opinions` Claims Advocacy and more` helping individuals and families navigate the healthcare system while reducing unnecessary elective surgeries and driving patients to the highest quality providers. The result is better care for patients` more empowered healthcare decisions for employees and their families` and a better bottom line for business. Headquartered outside Boston in Pembroke` MA` ConsumerMedical employs over100 people.